How to assess coronary artery remodeling by intravascular ultrasound

被引：4

作者：

Schartl, Michael ^{[1
]}

Bocksch, Wolfgang ^{[1
]}

机构：

[1] Univ Klinikum Charite, Dept Cardiol, D-13353 Berlin, Germany

来源：

AMERICAN HEART JOURNAL | 2006年 / 152卷 / 03期

关键词：

D O I：

10.1016/j.ahj.2006.02.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：414 / 416

页数：3

共 15 条

[1]

GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431

[2]

GLAGOV S, 1987, NEW ENGL J MED, V316, P13371

[3] Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries [J].

Hamasaki, S ;

Higano, ST ;

Al Suwaidi, J ;

Nishimura, RA ;

Miyauchi, K ;

Holmes, DR ;

Lerman, A .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) :737-743

[4] Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound [J].

Hibi, K ;

Ward, MR ;

Honda, Y ;

Suzuki, T ;

Jeremias, A ;

Okura, H ;

Hassan, AHM ;

Maehara, A ;

Yeung, AC ;

Pasterkamp, G ;

Fitzgerald, PJ ;

Yock, PG .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (02) :233-239

[5] Regression of coronary atherosclerosis by simvastatin - A serial intravascular ultrasound study [J].

Jensen, LO ;

Thayssen, P ;

Pedersen, KE ;

Stender, S ;

Haghfelt, T .

CIRCULATION, 2004, 110 (03) :265-270

[6] American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) - A report of the American College of Cardiology Task Force on Clinical Expert Consensus - Documents developed in collaboration with the European Society of Cardiology endorsed by the Society of Cardiac Angiography and Interventions [J].

Mintz, GS ;

Nissen, SE ;

Anderson, WD ;

Bailey, SR ;

Erbel, R ;

Fitzgerald, PJ ;

Pinto, FJ ;

Rosenfield, K ;

Siegel, RJ ;

Tuzcu, EM ;

Yock, PG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1478-1492

[7] Effect of Atorvastatin (80 mg/day) versus Pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study) [J].

Nicholls, SJ ;

Tuzcu, EM ;

Schoenhagen, P ;

Sipahi, I ;

Crowe, T ;

Kapadia, S ;

Nissen, SE .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (12) :1636-1639

[8] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[9] PARADOXICAL ARTERIAL-WALL SHRINKAGE MAY CONTRIBUTE TO LUMINAL NARROWING OF HUMAN ATHEROSCLEROTIC FEMORAL ARTERIES [J].

PASTERKAMP, G ;

WENSING, PJW ;

POST, MJ ;

HILLEN, B ;

MALI, WPTM ;

BORST, C .

CIRCULATION, 1995, 91 (05) :1444-1449

[10] Effects of lipid-lowering therapy on coronary artery remodeling [J].

Schartl, M ;

Bocksch, W ;

Fateh-Moghadam, S .

CORONARY ARTERY DISEASE, 2004, 15 (01) :45-51

← 1 2 →